Skip to main content

Advertisement

MalVac: Database of malarial vaccine candidates

Article metrics

Abstract

Background

The sequencing of genomes of the Plasmodium species causing malaria, offers immense opportunities to aid in the development of new therapeutics and vaccine candidates through Bioinformatics tools and resources.

Methods

The starting point of MalVac database is the collection of known vaccine candidates and a set of predicted vaccine candidates identified from the whole proteome sequences of Plasmodium species provided by PlasmoDb 5.4 release (31st October 2007). These predicted vaccine candidates are the adhesins and adhesin-like proteins from Plasmodium species, Plasmodium falciparum, Plasmodium vivax and Plasmodium yoelii. Subsequently, these protein sequences were analysed through 20 publicly available algorithms to obtain Orthologs, Paralogs, BetaWraps, TargetP, TMHMM, SignalP, CDDSearch, BLAST with Human Ref. Proteins, T-cell epitopes, B-cell epitopes, Discotopes, and allergen predictions. All of this information was collected and organized with the ORFids of the protein sequences as primary keys. This information is relevant from the view point of Reverse Vaccinology in facilitating decision making on the most probable choice for vaccine strategy.

Results

Detailed information on the patterning of the epitopes and other motifs of importance from the viewpoint of reverse vaccinology has been obtained on the most probable protein candidates for vaccine investigation from three major malarial species. Analysis data are available on 161 adhesin proteins from P. falciparum, 137 adhesin proteins from P. vivax and 34 adhesin proteins from P. yoelii. The results are displayed in convenient tabular format and a facility to export the entire data has been provided. The MalVac database is a "community resource". Users are encouraged to export data and further contribute by value addition. Value added data may be sent back to the community either through MalVac or PlasmoDB.

Conclusion

A web server MalVac for facilitation of the identification of probable vaccine candidates has been developed and can be freely accessed.

Background

Malaria is a major killer disease. Annually, about 500 million people get infected and an estimated 1 million deaths occur. Despite numerous efforts we still do not have effective vaccines [1]. Among the parasites that cause malaria, the most common and widely distributed is Plasmodium vivax [2]. But the most fatal form of malaria is caused by Plasmodium falciparum [3]. Plasmodium yoelii is a commonly used rodent malaria parasite as a model to study malaria infection. Malaria caused by P. yoelii has similarities to that caused by P. falciparum and P. vivax [4].

Currently, several vaccines against multiple stages are in clinical development, including pre-erythrocytic, blood stage and others [3]. Although these advancements raise the hopes of the availability of an effective vaccine, it is noted that our limited knowledge on the details of the immune responses is becoming a major handicap [1]. The availability of complete genome sequences of Plasmodium falciparum [5], P. yoelii [4] and P. vivax has provided new opportunity for applying the principles of Reverse Vaccinology. Reverse vaccinology uses bioinformatics in the initial steps to identify potential antigens, which are subsequently examined for their efficacy and toxicity. In its maiden application, use of algorithm for prediction of sub-cellular location boosted the power of identifying potential vaccine candidates [6]. Subsequently, enhancements have been proposed to reverse vaccinology by suggesting the use of additional algorithms to find probability of being an adhesin, of topology (transmembrane regions) and to find similarity with host protein [7].

Recently, integrative approaches are proposed for Reverse Vaccinology by including prediction of multiple features of proteins [8]. Adopting this strategy, the following predictions were incorporated: of adhesins [9] and their orthologs [10], paralogs [11], transmembrane topologies [12], beta helix supersecondary structural motifs [13], subcellular localization [14, 15], similarity against Human proteins [16], antigenic regions [17], conserved domains[18], epitopes [1926] and allergens [2729]. The work flow started with adhesin prediction algorithm, which holds an important position in vaccine development process. The adhesin proteins mediate the adherence of malaria parasites to the host cells and facilitate invasion. Targeting these adhesins to abrogate the colonization process can prevent malaria infection [9, 30].

The multiple features of potential vaccine candidates coupled with information on the current candidates being pursued can be queried through a user friendly interface. These data are housed in MalVac database, which can aid in the discovery of adhesin based vaccines.

Methods

Database architecture

The ORF identification tags (ORF ID) assigned to proteins of malaria parasites as given in PlasmoDB 5.4 release of 31st October 2007 [31] were used as primary keys. The database was developed using MySQL version 4.1.20 at back end and operated in Red Hat Enterprise Linux ES release 4. The web interfaces have been developed in HTML and PHP 5.1.4, which dynamically execute the MySQL queries to fetch the stored data and is run through Apache2 server. The overall layout of MalVac is provided in Figure 1.

Figure 1
figure1

The MalVac layout. All data are organized in relation to the primary key ORF ID.

The first step towards MalVac database creation is the collection of known vaccine candidates and a set of predicted vaccine candidates identified from the whole proteome sequences of Plasmodium species provided by PlasmoDB 5.4 release(31st October 2007). These predicted vaccine candidates are the adhesins and adhesin-like proteins from Plasmodium species, P. falciparum, P. vivax and P. yoelii using MAAP server [9]. Subsequently these protein sequences were analysed with 20 algorithms important from the view of reverse vaccinology (Table 1).

Table 1 Algorithms used to predict molecular features of potential malarial vaccine candidates and housed in MalVac.

Database access and interface

MalVac Database is freely available [32]. A user friendly web-based interface allows users to explore the site and fetch the data corresponding to their queries. For example, if the user needs to search database for data on a set of proteins given by their ORF identification tags one starts with clicking the "Database Search" button (Figure 2). This would take the user to the "MalVac Query Page". Here the user can search the database for adhesin proteins and their attributes corresponding to one or more ORF identification tags of a species or against a specific Keyword. To fetch the required data the corresponding checkboxes need to be toggled 'on' followed by clicking the submit button (Figure 3). The results are displayed in convenient tabular format and a facility to export the entire data has been provided. To get the Epitope and Allergen data the user must provide a specific ORF ID along with the species selected.

Figure 2
figure2

The Home page of MalVac. The "Database Search" facility can be used for first level search. Advanced search is provided in the "Search Tools" facility. "Other links" would take users to other websites of malaria for obtaining additional details and the "Known Vaccines" tab describes the details of the currently known vaccine candidates.

Figure 3
figure3

The MalVac Query Page. Default selections are MAAP score and ORF ID.

Advanced search facility of predicted malarial adhesins is also provided where the results can be filtered on the basis of Protein length, number of transmembrane spanning regions, localization and reliability class, presence or absence of betawraps, paralogs, orthologs, hits to Conserved Domain Database and Human Reference proteins (retrieved from NCBI through ftp on April 22, 2008). The results obtained can be exported by the user. The known vaccines link takes user to the page containing the list of known vaccine candidates provided in tabular form. This data can again be exported by the user. Facility to post comments by the user has been provided in MalVac web interface. Users can post their value added comments and suggestions on specific genes based on their own experience through the comment posting page of MalVac.

Results and Discussion

MalVac Database contains analysis data on 332 potential vaccine candidates on three most important Plasmodium species. Of these, 161 are from P. falciparum, 137 are from P. vivax and 34 are from P. yoelii. First level of searching and retrieval of data is possible either through ORF ID or keywords. Multiple ORF IDs can be submitted using comma separation. Keywords can be used singly. If multiple keywords are used then the search is implemented using the AND Boolean. In the case of searching for epitope data, due to their huge size, data are conveniently retrieved in a singular mode for each ORF ID specifically. All data can be exported conveniently as a text file.

The database houses detailed information on these vaccine candidates analysed through 20 algorithms important from the view of reverse vaccinology. The analysis through these algorithms provide a broad range of information regarding Orthologs, Paralogs, BetaWraps, Localization, Transmembrane spanning regions, Signal Peptides, Conserved domains, similarity to Human Reference Proteins, T-cell epitopes, B-cell epitopes, Discotopes, and Allergen predictions.

Advanced level searches are also provided. In this facility users can search using combined feature selection. The most immediate application of such a scheme is in filtering for candidate proteins meeting a certain set of specifications. For example users formulate their queries by selecting for proteins that have less (or greater) than a specified number of transmembrane domains and less (or greater) than a specified length of protein. The features on which users can formulate their search could be based on Protein length, number of transmembrane spanning regions, localization-reliability class, presence or absence of betawraps, paralogs, orthologs, hits to CDD and human reference proteins in the advanced search page. The results obtained can be exported by the user.

Conclusion

MalVac database was built as a community resource to aid malaria vaccinologists. MalVac is freely available with facility to export data and use for user's convenience [32].

References

  1. 1.

    Thompson J, Millington OR, Garside P, Brewer JM: What can transgenic parasites tell us about the development of Plasmodium-specific immune responses?. Parasite Immunol. 2008, 30: 223-233.

  2. 2.

    Sina B: Focus on Plasmodium vivax. Trends Parasitol. 2002, 18: 287-289.

  3. 3.

    Todryk SM, Hill AV: Malaria Vaccines: the stage we are at. Nat Rev Microbiol. 2007, 5: 487-489.

  4. 4.

    Carlton JM, Angiuoli SV, Suh BB, Kooij TW, Pertea M, Silva JC, Ermolaeva MD, Allen JE, Selengut JD, Koo HL, Peterson JD, Pop M, Kosack DS, Shumway MF, Bidwell SL, Shallom SJ, van Aken SE, Riedmuller SB, Feldblyum TV, Cho JK, Quackenbush J, Sedegah M, Shoaibi A, Cummings LM, Florens L, Yates JR, Raine JD, Sinden RE, Harris MA, Cunningham DA, Preiser PR, Bergman LW, Vaidya AB, van Lin LH, Janse CJ, Waters AP, Smith HO, White OR, Salzberg SL, Venter JC, Fraser CM, Hoffman SL, Gardner MJ, Carucci DJ: Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii yoelii. Nature. 2002, 419: 512-519.

  5. 5.

    Gardner MJ, Hall N, Fung E, White O, Berriman M, Hyman RW, Carlton JM, Pain A, Nelson KE, Bowman S, Paulsen IT, James K, Eisen JA, Rutherford K, Salzberg SL, Craig A, Kyes S, Chan MS, Nene V, Shallom SJ, Suh B, Peterson J, Angiuoli S, Pertea M, Allen J, Selengut J, Haft D, Mather MW, Vaidya AB, Martin DM, Fairlamb AH, Fraunholz MJ, Roos DS, Ralph SA, McFadden GI, Cummings LM, Subramanian GM, Mungall C, Venter JC, Carucci DJ, Hoffman SL, Newbold C, Davis RW, Fraser CM, Barrell B: Genome sequence of the human malaria parasite Plasmodium falciparum. Nature. 2002, 419: 498-511.

  6. 6.

    Serruto D, Rappuoli R: Post-genomic vaccine development. FEBS Lett. 2006, 580: 2985-2992.

  7. 7.

    Vivona S, Bernante F, Filippini F: Nerve: New Enhanced Reverse Vaccinology Environment. BMC Biotechnol. 2006, 6: 35-

  8. 8.

    Vivona S, Gardy JL, Ramachandran S, Brinkman FS, Raghava GP, Flower DR, Filippini F: Computer-aided biotechnology: from immuno-informatics to reverse vaccinology. Trends Biotechnol. 2008, 26: 190-200.

  9. 9.

    Ansari FA, Kumar N, Bala Subramanyam M, Gnanamani M, Ramachandran S: MAAP: Malarial adhesins and adhesin-like proteins predictor. Proteins. 2008, 70: 659-666.

  10. 10.

    Chen F, Mackey AJ, Stoeckert CJ, Roos DS: OrthoMCL-DB: querying a comprehensive multi-species collection of ortholog groups. Nucleic Acid Res. 2006, D363-368. 34 Database

  11. 11.

    Kondrashov FA, Rogozin IB, Wolf YI, Koonin EV: Selection in the evolution of gene duplications. Genome Biol. 2002, 3: RESEARCH0008-

  12. 12.

    Krogh A, Larsson B, von Heijne G, Sonnhammer EL: Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol. 2001, 305: 567-580.

  13. 13.

    Bradley P, Cowen L, Menke M, King J, Berger B: BETAWRAP: successful prediction of parallel beta-helices from primary sequence reveals an association with many microbial pathogens. Proc Natl Acad Sci USA. 2001, 98: 14819-14824.

  14. 14.

    Emanuelsson O, Nielsen H, Brunak S, von Heijne G: Predicting subcellular localization of proteins based on their N-terminal amino acid sequence. J Mol Biol. 2000, 300: 1005-1016.

  15. 15.

    Bendtsen JD, Nielsen H, von Heijne G, Brunak S: Improved prediction of signal peptides: SignalP 3.0. J Mol Biol. 2004, 340: 783-795.

  16. 16.

    Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ: Basic local alignment search tool. J Mol Biol. 1990, 215: 403-410.

  17. 17.

    Kolaskar AS, Tongaonkar PC: A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett. 1990, 276: 172-174.

  18. 18.

    Marchler-Bauer A, Anderson JB, Cherukuri PF, DeWeese-Scott C, Geer LY, Gwadz M, He S, Hurwitz DI, Jackson JD, Ke Z, Lanczycki CJ, Liebert CA, Liu C, Lu F, Marchler GH, Mullokandov M, Shoemaker BA, Simonyan V, Song JS, Thiessen PA, Yamashita RA, Yin JJ, Zhang D, Bryant SH: CDD: a Conserved Domain Database for protein classification. Nucleic Acids Res. 2005, D192-196. 33 Database

  19. 19.

    Saha S, Raghava GP: Prediction of Continuous B-cell Epitopes in an Antigen Using Recurrent Neural Network. Proteins. 2006, 65: 40-48.

  20. 20.

    Saha S, Raghava GP: Prediction methods for B-cell epitopes. Methods Mol Biol. 2007, 409: 387-394.

  21. 21.

    Andersen H P, Nielsen M, Lund O: Prediction of residues in discontinuous B cell epitopes using protein 3D structures. Protein Science. 2006, 15: 2558-2567.

  22. 22.

    Kulkarni-Kale U, Bhosle S, Kolaskar AS: CEP: a conformational epitope prediction server. Nucleic Acids Res. 2005, W168-171. 33 Web Server

  23. 23.

    Buus S, Lauemoller SL, Worning P, Kesmir C, Frimurer T, Corbet S, Fomsgaard A, Hilden J, Holm A, Brunak S: Sensitive quantitative predictions of peptide-MHC binding by a 'Query by Committee' artificial neural network approach. Tissue Antigens. 2003, 62: 378-384.

  24. 24.

    Guan P, Doytchinova IA, Zygouri C, Flower DR: MHCPred: bringing a quantitative dimension to the online prediction of MHC binding. Appl Bioinformatics. 2003, 2: 63-66.

  25. 25.

    Parker KC, Bednarek MA, Coligan JE: Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol. 1994, 152: 163-175.

  26. 26.

    Singh H, Raghava GP: ProPred: Prediction of HLA-DR binding sites. Bioinformatics. 2001, 17: 1236-1237.

  27. 27.

    Saha S, Raghava GP: AlgPred: prediction of allergenic proteins and mapping of IgE epitopes. Nucleic Acids Res. 2006, W202-209. 34 Web Server

  28. 28.

    Fiers MW, Kleter GA, Nijland H, Peijnenburg AA, Nap JP, van Ham RC: Allermatch, a webtool for the prediction of potential allergenicity according to current FAO/WHO Codex alimentarius guidelines. BMC Bioinformatics. 2004, 5: 133-

  29. 29.

    Riaz T, Hor HL, Krishnan A, Tang F, Li KB: WebAllergen: a web server for predicting allergenic proteins. Bioinformatics. 2005, 21: 2570-2571.

  30. 30.

    Wizemann TM, Adamou JE, Langermann S: Adhesins as targets for vaccine development. Emerg Infect Dis. 1999, 5: 395-403.

  31. 31.

    Bahl A, Brunk B, Crabtree J, Fraunholz MJ, Gajria B, Grant GR, Ginsburg H, Gupta D, Kissinger JC, Labo P, Li L, Mailman MD, Milgram AJ, Pearson DS, Roos DS, Schug J, Stoeckert CJ, Whetzel P: PlasmoDB: the Plasmodium genome resource. A database integrating experimental and computational data. Nucleic Acids Res. 2003, 31: 212-215.

  32. 32.

    MalVac: Database of Malarial Vaccine Candidates A Community Resource. [http://malvac.igib.res.in/]

Download references

Acknowledgements

SR thanks the NMITLI project on Plasmodium falciparum annotation and CMM0017 Task force on "Drug target development using in silico biology" for financial support and Raghunandan for systems support. RG thanks ICMR for a fellowship.

Author information

Correspondence to Srinivasan Ramachandran.

Additional information

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

SR conceived the idea and provided guidance, suggestions, critical comments, and testing of MalVac. RG, SA, FAA, HVS collected data, organized systematically, prepared the codes for MalVac. SR and RG wrote the manuscript. All authors read and approved the final manuscript.

Rupanjali Chaudhuri, Shakil Ahmed, Faraz Alam Ansari contributed equally to this work.

Authors’ original submitted files for images

Below are the links to the authors’ original submitted files for images.

Authors’ original file for figure 1

Authors’ original file for figure 2

Authors’ original file for figure 3

Rights and permissions

Reprints and Permissions

About this article

Keywords

  • Malaria
  • Vaccine Candidate
  • Plasmodium Species
  • Potential Vaccine Candidate
  • Rodent Malaria Parasite

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate. Please note that comments may be removed without notice if they are flagged by another user or do not comply with our community guidelines.